Economic impact of using maternal plasma cell‐free DNA testing to guide further workup in recurrent pregnancy loss

OBJECTIVE: We have previously demonstrated that maternal‐plasma cell‐free DNA (cfDNA)‐testing can detect chromosomal anomalies in recurrent pregnancy loss (RPL) with 81.8% sensitivity and 90.3% specificity. Here we assess whether this is cost effective in guiding further workup in RPLs. METHOD: A de...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Siyang, Bhatt, Sucheta, Borrell, Antoni, Yaron, Yuval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518071/
https://www.ncbi.nlm.nih.gov/pubmed/34002411
http://dx.doi.org/10.1002/pd.5972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518071/
https://www.ncbi.nlm.nih.gov/pubmed/34002411
http://dx.doi.org/10.1002/pd.5972

Ejemplares similares